XML 30 R2.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Balance Sheets - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Current Assets:    
Cash and cash equivalents $ 4,328,355 $ 6,540,794
Accounts receivable, net 134,006 382,258
Inventories, net 454,379 256,149
Prepaid expenses and other current assets 786,732 695,276
Total Current Assets 5,703,472 7,874,477
Restricted cash 75,000 75,000
Deferred offering costs 133,976 144,582
Equipment, net 170,330 187,513
Total Assets 6,082,778 8,281,572
Current Liabilities:    
Accounts payable and other accrued expenses 1,552,307 1,743,427
Derivative liabilities 43,942 3,661
Deferred revenue 2,942 1,990
Customer advance payments 63,567 106,609
Total Current Liabilities 1,662,758 1,855,687
Non-Current Liabilities 1,495  
Total Liabilities 1,664,253 1,855,687
Commitments and Contingencies
Stockholders’ Equity:    
Common stock par value $0.0001 per share, 100,000,000 shares authorized; 17,189,737 and 12,450,187 shares issued as of September 30, 2019 and December 31, 2018, respectively; and 17,188,929 and 12,449,379 shares outstanding at September 30, 2019 and December 31, 2018, respectively 1,716 1,245
Additional paid-in capital 57,787,751 51,720,630
Accumulated deficit (53,364,478) (45,289,526)
Treasury stock, 808 shares at cost (6,464) (6,464)
Total Stockholders’ Equity 4,418,525 6,425,885
Total Liabilities and Stockholders’ Equity $ 6,082,778 $ 8,281,572